Jose Meller is a Cardiology physician. OpenAlex indexes 80 publications with 3,046 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
35 E 85th St Ofc 2
New York, NY 100280962
Telephone
212-988-3772Provider last certified this registry record 6 Mar 2023.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202511 payments
- Novartis Pharmaceuticals CorporationProgram year202511 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.2%Statin16.5%Atorvastatin Calcium57%Rosuvastatin Calcium32%Simvastatin6%Livalo2%Pitavastatin Calcium2%Crestor1%Pravastatin Sodium1%Part D<11 patientsBeta blocker12.7%Metoprolol Succinate46%Metoprolol Tartrate18%Nebivolol Hcl11%Carvedilol10%Atenolol6%Propranolol Hcl5%Bisoprolol Fumarate2%Bystolic2%Tenormin1%Part D<11 patients+ 15 more classes in this area
Blood & clotting
12.7%Factor Xa inhibitor9.6%Eliquis57%Xarelto43%Part D≥89 patientsP2Y12 inhibitor2.5%Clopidogrel87%Prasugrel Hcl7%Brilinta6%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
8.1%SGLT2 inhibitor3%Jardiance84%Farxiga16%Part D<11 patientsBiguanide (metformin)1.4%Metformin Hcl92%Metformin Hcl Er9%Part D<11 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI
JACC: Cardiovascular Interventions
2021 - Relation between exercise-induced changes in ejection fraction and systolic loading conditions at rest in aortic regurgitation
Journal of the American College of Cardiology
1984 - Hyperkalemia-induced pseudoinfarction pattern.
PubMed
1984
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”